For the Inventor, By the Inventor

Enter assignee name

Leipzig, Germany

The Medicines Company (Leipzig) Gmbh

Calculating rank

USPTO Granted Patents = 16

% Expired Patents = 93.8

Forward Citations = 68

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Andrea Schweinitz (13 out of 15 patents)

Torsten Steinmetzer (11 out of 17 patents)

Alexander Schulze (8 out of 8 patents)

4. Claudia Reichelt (8 out of 8 patents)

5. Friedrich-Alexander Ludwig (7 out of 7 patents)

6. Mohammed Daghish (7 out of 7 patents)

7. Jochen Heinicke (5 out of 5 patents)

8. Joerg Stuerzebecher (5 out of 7 patents)

9. Jörg Stürzebecher (4 out of 6 patents)

10. Stjepan Jelakovic (3 out of 13 patents)

11. Peter Herold (3 out of 54 patents)

12. Peter Steinmetzer (3 out of 3 patents)

13. Anett Soeffing (3 out of 3 patents)

14. Silke Nicklisch (3 out of 3 patents)

15. Andreas Van De Locht (3 out of 3 patents)

16 patents: Sort by Forward Citations

1. 9611290 - Trypsin-like serine protease inhibitors, and their preparation and use (2017-04-04),

2. 9365613 - Acylated 4-amidino- and -4-guanidinobenzylamines for inhibition of plasma kallikrein (2016-06-14),

3. 9090658 - Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof (2015-07-28),

4. 8921319 - Serine protease inhibitors (2014-12-30),

5. 8664233 - Substituted 5H-pyrimido[5,4-B]indoles, method for the production thereof and use thereof for treating non-solid malignant tumors of the blood-producing system (2014-03-04),

6. 8598206 - Trypsin-like serine protease inhibitors, and their preparation and use (2013-12-03),

7. 8569313 - Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors (2013-10-29),

8. 8513461 - Trypsin-like serine protease inhibitors, and their preparation and use (2013-08-20),

9. 8497245 - Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa (2013-07-30),

10. 8476306 - Urokinase inhibitors, production and use thereof (2013-07-02),

11. 8410310 - Trypsin-like serine protease inhibitors, and their preparation and use (2013-04-02),

12. 8207378 - Trypsin-like serine protease inhibitors, and their preparation and use (2012-06-26),

13. 8124587 - 2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor Xa (2012-02-28),

14. 8058285 - Substituted pyrido [3', 2′: 4, 5] thieno [3, 2-D] pyrimidines and pyrido [3′, 2′: 4, 5] furo [3, 2-D] pyrimidines used as inhibitors of the PDE-4 and/or the release of TNF-ALPHA (2011-11-15),

15. 7838560 - Urokinase inhibitors, production and use thereof (2010-11-23),

Company Overview

The Medicines Company (Leipzig) GmbH is a biopharmaceutical organization focused on developing innovative therapies to address critical medical needs. Specializing in the research and development of novel treatments, the company emphasizes advancements in cardiovascular and infectious diseases. With a commitment to improving patient outcomes, it leverages cutting-edge technology and scientific expertise to bring new solutions to the healthcare market, primarily serving the European region.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

16 Patents

#5 in Leipzig

#2,629 in Germany

#37,914 in the World

Leipzig, Germany

The Medicines Company (Leipzig) Gmbh

Forward Citations = 68

33 inventors:

Andrea Schweinitz (13 out of 15 patents)

Torsten Steinmetzer (11 out of 17 patents)

Alexander Schulze (8 out of 8 patents)

4. Claudia Reichelt (8 out of 8 patents)

5. Friedrich-Alexander Ludwig (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: The Medicines Company (Leipzig) Gmbh. Retrieved from https://idiyas.com/company/medicines-company-leipzig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…